Increased expression of ALCAM/CD166 in pancreatic cancer is an independent prognostic marker for poor survival and early tumour relapse

被引：0
|
作者：
C Kahlert
H Weber
C Mogler
F Bergmann
P Schirmacher
H G Kenngott
U Matterne
N Mollberg
N N Rahbari
U Hinz
M Koch
M Aigner
J Weitz
机构：
[1] University of Heidelberg,Department of Surgery
[2] Im Neuenheimer Feld 110,undefined
[3] Institute of Pathology,undefined
[4] University of Heidelberg,undefined
[5] Im Neuenheimer Feld 110,undefined
[6] Institute of Occupational and Social medicine,undefined
[7] Voßstrasse 2,undefined
来源：
British Journal of Cancer | 2009年 / 101卷
关键词：
ALCAM; CD166; ADAM17/TACE; pancreatic cancer; prognostic marker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：457 / 464
页数：7
相关论文
共 50 条
  • [41] Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
    Lugli, A.
    Iezzi, G.
    Hostettler, I.
    Muraro, M. G.
    Mele, V.
    Tornillo, L.
    Carafa, V.
    Spagnoli, G.
    Terracciano, L.
    Zlobec, I.
    BRITISH JOURNAL OF CANCER, 2010, 103 (03) : 382 - 390
  • [42] Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer
    A Lugli
    G Iezzi
    I Hostettler
    M G Muraro
    V Mele
    L Tornillo
    V Carafa
    G Spagnoli
    L Terracciano
    I Zlobec
    British Journal of Cancer, 2010, 103 : 382 - 390
  • [43] Upregulation of microRNA-191 can serve as an independent prognostic marker for poor survival in prostate cancer
    Liu, Jing-bo
    Yan, Yong-ji
    Shi, Jing
    Wu, Ya-bing
    Li, Yan-feng
    Dai, Lin-feng
    Ma, Xue-tao
    MEDICINE, 2019, 98 (29)
  • [44] A CD44-/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer
    Ahmed, Mohamed A. H.
    Aleskandarany, Mohammed A.
    Rakha, Emad A.
    Moustafa, Radwa Z. A.
    Benhasouna, Ahmed
    Nolan, Christopher
    Green, Andrew R.
    Ilyas, Mohammad
    Ellis, Ian O.
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 133 (03) : 979 - 995
  • [45] A CD44-/CD24+Phenotype Is a Poor Prognostic Marker in Early Invasive Breast Cancer
    Ahmed, M. A. H.
    Aleskandarany, M. A.
    Rakha, E. A.
    Moustafa, R.
    Benhasouna, A.
    Nolan, C.
    Green, A. R.
    Ilyas, M.
    Ellis, I. O.
    JOURNAL OF PATHOLOGY, 2012, 226 : S11 - S11
  • [46] A CD44−/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer
    Mohamed A. H. Ahmed
    Mohammed A. Aleskandarany
    Emad A. Rakha
    Radwa Z. A. Moustafa
    Ahmed Benhasouna
    Christopher Nolan
    Andrew R. Green
    Mohammad Ilyas
    Ian O. Ellis
    Breast Cancer Research and Treatment, 2012, 133 : 979 - 995
  • [47] Low expression of aldehyde deyhdrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer
    Kahlert, Christoph
    Bergmann, Frank
    Beck, Janine
    Welsch, Thilo
    Mogler, Carolin
    Herpel, Esther
    Dutta, Shamik
    Niemietz, Thomas
    Koch, Moritz
    Weitz, Juergen
    BMC CANCER, 2011, 11
  • [48] Overexpression of RalBP1 in colorectal cancer is an independent predictor of poor survival and early tumor relapse
    Mollberg, Nathan M.
    Steinert, Gunnar
    Aigner, Maximillian
    Hamm, Alexander
    Lin, Fang-Ju
    Elbers, Heike
    Reissfelder, Christoph
    Weitz, Juergen
    Buechler, Markus W.
    Koch, Moritz
    CANCER BIOLOGY & THERAPY, 2012, 13 (08) : 694 - 700
  • [49] CD10 expression in stromal cells of patients with breast cancer: a poor prognostic marker
    Bacha, Dhouha
    Ben Amor, Anissa
    Ben Farhat, Farah
    Ben Slama, Sana
    Lahmar, Ahlem
    Bouraoui, Saadia
    Triki, Amel
    PAN AFRICAN MEDICAL JOURNAL, 2020, 37 : 1 - 14
  • [50] Low expression of aldehyde deyhdrogenase 1A1 (ALDH1A1) is a prognostic marker for poor survival in pancreatic cancer
    Christoph Kahlert
    Frank Bergmann
    Janine Beck
    Thilo Welsch
    Carolin Mogler
    Esther Herpel
    Shamik Dutta
    Thomas Niemietz
    Moritz Koch
    Jürgen Weitz
    BMC Cancer, 11
12345